CLINICAL_TRIALS
trial_result
· 2011-06-27
Clinical Trial Update: A Safety Comparison of Iopromide and Iodixanol in Renal Impaired Patients [Phase 4]
Summary
This Phase 4 trial update compares the safety of the contrast agents iopromide and iodixanol in patients with chronic kidney disease.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Chinese PLA General Hospital | Conditions: Kidney Failure, Chronic | Phase 4 | Status: COMPLETED